巨星医疗控股（02393.HK）3月19日发布盈利警告，基于对截至2025年12月31日止财年（“2025财年”）最新未经审核管理账目及可获取资料的初步评估，公司预计期内将录得不少于0.65亿元人民币的综合净亏损，较2024财年9.035亿元的净利润出现明显倒退。 \n\n公司表示，由盈转亏主要受两项因素影响： \n1. 2024财年曾因以折让价赎回2026年到期的优先票据，确认一次性收益约10.834亿元；2025财年不再有该一次性收益。 \n2. 2025财年将确认非金融资产减值损失。 \n\n巨星医疗控股指出，相关数据尚待进一步内部审阅，2025财年经审计的综合业绩将于2026年3月27日公布。公司提醒股东及潜在投资者在买卖公司股份时保持审慎。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.